BA vs WHWK · P/E 89, rev $24.56B vs $202.8M cap
The Boeing Company (BA) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2026-06-30 was $24.56B. Net income was -$444.0M. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the BA and WHWK stock pages for the full models.
Not investment advice.